Five join MHRA's BP Commission
This article was originally published in Scrip
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency (MHRA)'s British Pharmacopoeia Commission, which is responsible for preparing new editions of the BP and the BP (Veterinary), has appointed five new members: Andrew Coulson, a member of the Royal College of Veterinary Surgeons; Dr Gerard Lee, who worked at the MHRA from 1999 to December 2011, most recently as group manager of the British Pharmacopoeia and Laboratory Services section; Dr Ronald Torano, a GlaxoSmithKline employee since 1989 and currently pharmacopoeial intelligence and advisory specialist; Dr Paul Varley, vice-president of biopharmaceutical development at Medimmune; and Professor John Miller, visiting professor to the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde, and former head of laboratory department for the Council of Europe's EDQM.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.